Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

GoPro Stock Is on a Tear Fueled by Online Sales and Subscriptions Growth

GoPro stock is on a tear based on its online sales and subscription growth. However, investors should be skeptical.

Why Netflix Stock Will Still Be Relevant Post-Pandemic

Although Netflix stock already jumped higher due to the pandemic, the extended new normal is still a catalyst for the streaming giant.

Tesla’s Momentum May Have It Tripping After the Pandemic

TSLA stock has delivered great profit to its investors over the last year, but all good times end when expectations get unreasonable.

A Long and Winding Road for Luckin Coffee

Luckin Coffee is moving in the right direction but still has immense challenges ahead, making Luckin stock a risky bet at this stage.

The Turnaround Thesis Is Surprisingly Strong with Luckin Coffee

As Luckin stock bulls fight to stay above the penny-stock threshold, a recent executive-level re-addition could signal a stunning comeback.

Naked Brands Making a Comeback Seems Virtually Impossible

NAKD Stock will continue on its downward spiral until Naked Group finds its path to profitability which seems highly unlikely

Get Exposure to a Wide Variety of Markets via SPI Energy

Is it problematic to be involved in highly disparate sectors? We'll take a closer look so SBI Energy stock holders can decide for themselves.

Don’t Count on a ‘Marijuana Moment’ with Hexo

The decline in Hexo stock has been relentless, and a prominent politician taking a pro-legalization stance won't save investors now.

Aptinyx News: Why APTX Stock Is Skyrocketing Today

APTX stock is soaring on Tuesday after Aptinyx announced very positive results from its trial for a treatment for those with PTSD.

7 Monster Growth Stocks With Double-Digit Upside

With several growth stocks encountering a steep discount from the coronavirus panic, many early speculators have benefitted tremendously. However, those getting in late to the game still have a chance at upside.

Array Technologies Stock Is an IPO Winner, but Flex Stock Is a Better Buy

Array Technologies is an IPO winner, even though it's low technology. Buy Flex stock instead of Array Technologies stock, since it is likely to spin off or carve out its Nextracker division.

Why Catalyst Pharmaceuticals Stock Is Feeling the ‘Bern’

Typically, a major clinical victory would boost names like Catalyst Pharmaceuticals stock. Unfortunately, some political rumblings and an unexpected competitor got in the way of CPRX.

Looking At Lockheed Martin Stock Ahead of Earnings

Lockheed Martin is an inexpensive free cash flow powerhouse. But LMT stock is worth more based on its historical and peer valuation.

Sorrento Therapeutics Isn’t the Way to Play Covid Stocks

There are several established biotech companies for investors to consider but they should avoid buying SRNE stock.

Lordstown Motors’ EV Lane May Be Crowded

DiamondPeak stock changes to RIDE after it merges with Lordstown Motors. Is it a case of one electric vehicle maker too many?     

Wait for a Pullback to Buy Steady Procter & Gamble Stock

Investors are better off waiting for a pullback to purchase Procter & Gamble stock. Here's what you need to know ahead of earnings.

Delve into an Underappreciated Health Care Niche with TherapeuticsMD

Give TXMD stock a try if you're ready to expand your portfolio's horizons with a stake in innovative women's health care products.

Cybersecurity Stocks: Hackers Use Artificial Intelligence for a New Type of Security Breach

To make real money in the cybersecurity space, it’s all about investing in the best cybersecurity company. And Louis Navellier believes he's found just the one. 

The Low-Hanging Fruit for Covid-19 Vaccines Is Gone for iBio

With the viable candidate pool for novel coronavirus vaccines shrinking, this angle is probably closed to IBIO stock. However, speculators still have a shot with the therapeutic approach.